Table 3.
Relationship between S100A11 expression in tissues and clinicopathologic characteristics of 65 non‐small cell lung cancer patients
Variable | Different expression of S100A11 | P‐value | |
---|---|---|---|
Weak/moderate (–/+/++) (n = 35) | Strong (+++) (n = 30) | ||
Age, years (mean ± SD) | 58 ± 12 | 55 ± 13 | 0.342 † |
Sex (no. cases) | |||
Male | 27 | 26 | 0.359 ‡ |
Female | 8 | 4 | |
Histological subtype (no. cases) | |||
Adenocarcinoma | 16 | 14 | 1.000 ‡ |
Squamous cell carcinoma | 19 | 16 | |
Tumor–node–metastasis stage (no. cases) | |||
I, II | 26 | 10 | 0.001*, ‡ |
III, IV | 9 | 20 | |
Tumor status (no. cases) | |||
T1–2 | 27 | 18 | 0.180 ‡ |
T3–4 | 8 | 12 | |
Lymph node status (no. cases) | |||
N0 | 20 | 7 | 0.011*, ‡ |
N1–3 | 15 | 23 | |
Differentiation status (no. cases) | |||
Poorly differentiated | 15 | 7 | 0.246 § |
Moderately differentiated | 12 | 13 | |
Well differentiated | 8 | 10 |
P‐value <0.05;
Student's t‐test;
‡ Fisher's exact test;
Pearson χ2‐test.